25 June 2021
Today, leading hospital chain Fortis Healthcare rolled out Sputnik V, the third vaccine approved for India, for the general public at Fortis Hospital Mohali as part of the limited pilot soft launch. Around 200 people were vaccinated and registration for the vaccination can be done through the COWIN and Aarogya Setu applications. The vaccine stock has been directly procured by Fortis, from Dr. Reddy’s Laboratories, as per Government guidelines and has been priced at Rs. 1,145 (as per government guidelines – inclusive of administrative charges).
While Fortis Hospital Mohali continues to administer COVISHIELD AND COVAXIN, Sputnik V is also being made available to the public. Recent trials have shown that Sputnik V, has an efficacy of over 90% and will bring down symptomatic Covid-19 cases by over 90%, making it possible for India’s large population to be safe from infection from future virus strains. Fortis Healthcare ramped up its vaccination drive since April 2021 when vaccines were opened to all age groups above 18.
Abhijit Singh, Zonal Director, Fortis Hospital Mohali, said, “Fortis Hospital Mohali is the first hospital in the region to start vaccination for Sputnik V for the general public. The first day of vaccination got a good response from the people as around 200 people were vaccinated till Friday evening.”